Clinical trial
Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments
NCT05371483 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- May 18, 2022
- Completion date
- July 31, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.